Cipla has fully acquired Inzpera Healthsciences Limited, buying a 100% stake for approximately ₹110.65 Cr.

Inzpera specializes in pediatric pharmaceutical and wellness products.

This strategic move significantly strengthens Cipla's product portfolio and expands its reach in the high-growth children's health segment.

The acquisition aims to leverage Cipla's robust distribution network and operational scale, driving substantial growth and market penetration for its combined offerings in India.